Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
BACKGROUND: New prophylactic and therapeutic strategies to combat human infections with highly pathogenic avian influenza (HPAI) H5N1 viruses are needed. We generated neutralizing anti-H5N1 human monoclonal antibodies (mAbs) and tested their efficacy for prophylaxis and therapy in a murine model of...
Saved in:
| Main Author: | |
|---|---|
| Format: | Journal Article |
| Language: | English |
| Published: |
2018
|
| Online Access: | https://demo7.dspace.org/handle/123456789/134 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
- Antigenic Fingerprinting of H5N1 Avian Influenza Using Convalescent Sera and Monoclonal Antibodies Reveals Potential Vaccine and Diagnostic Targets
- Population-Level Antibody Estimates to Novel Influenza A/H7N9
- Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals
- Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
- Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia